forecast

Eli Lilly Using Obesity Drugs to Build Scale

Eli Lilly's GLP-1 franchise in obesity and possibly Alzheimer's, along with LillyDirect, gives it a long, protected revenue tail and a chance to use its winnings to build more control and power over the healthcare value chain.

forecastpending

Speaker

Anne-Marie Peterson

Evidence Quote

“If I were running Lilly, I would definitely be figuring out how to invest my winnings into having more control and power.”

Source

Anne-Marie Peterson - The Capital System - [Invest Like the Best, EP.364]— Invest Like the Best
Created: 11/14/2026, 4:41:01 AM

Your notes

Loading notes...